MoonLake Immunotherapeutics (MLTX)
NASDAQ: MLTX · Real-Time Price · USD
14.90
-0.10 (-0.67%)
At close: Dec 5, 2025, 4:00 PM EST
15.00
+0.10 (0.67%)
After-hours: Dec 5, 2025, 7:59 PM EST
MLTX Market Cap
MLTX has a market cap or net worth of $1.06 billion as of December 5, 2025. Its market cap has decreased by -65.82% in one year.
Market Cap
1.06B
Enterprise Value
758.71M
1-Year Change
-65.82%
Ranking
Category
Stock Price
$14.90
Market Cap Chart
Since February 14, 2022, MLTX's market cap has increased from $3.60M to $1.06B, an increase of 29,456.50%. That is a compound annual growth rate of 345.42%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 5, 2025 | 1.06B | -68.86% |
| Dec 31, 2024 | 3.41B | -5.66% |
| Dec 29, 2023 | 3.62B | 784.47% |
| Dec 30, 2022 | 409.26M | 11,274.54% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 908.36B |
| Johnson & Johnson | 487.83B |
| AbbVie | 404.22B |
| UnitedHealth Group | 302.09B |
| AstraZeneca | 279.81B |
| Novartis AG | 255.73B |
| Merck & Co. | 250.41B |
| Abbott Laboratories | 218.05B |